人类乳头瘤病毒 (HPV) 感染和疫苗接种和未接种巴拉圭年轻女性的风险行为
María Liz Bobadilla1,2, Verónica Villagra1, Héctor Castro3
1Laboratory of Immunology, Central Laboratory of Public Health, Minister of Public Health and Social Welfare, Asunción 1429, Paraguay.
Pathogens (Basel, Switzerland)
|March 27, 2024
概括
在18-25岁的巴拉圭妇女接种人类乳头瘤病毒 (HPV) 疫苗显著降低了HPV的流行率. 加达西尔-4疫苗在预防感染方面表现出有效性,而不会改变性行为.
科学领域:
- 妇科 妇科医生 妇科
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
背景情况:
- 宫癌是全球主要的健康问题,在女性中占第四位.
- 人类乳头瘤病毒 (HPV) 感染是导致子宫癌的主要原因.
- 预防性HPV疫苗接种是一个关键的预防措施.
研究的目的:
- 研究18-25岁的巴拉圭性活跃女性的HPV疫苗接种和性行为之间的关系.
- 评估Gardasil-4疫苗接种对这一人口群体HPV患病率的影响.
主要方法:
- 一项涉及254名18至25岁的性活跃巴拉圭妇女的研究.
- 用Gardasil-4接种疫苗的妇女和未接种疫苗的妇女之间的HPV患病率的比较.
- 在接种疫苗和未接种疫苗的两组中分析性行为模式.
主要成果:
- 40.9%的参与者接受了加达西尔-4疫苗.
- 在接种疫苗和未接种疫苗的组之间没有观察到性行为的显著差异.
- 接种疫苗的妇女在任何HPV类型 (37.5%对56.7%) 和高风险HPV类型 (26.0%对52.7%) 的患病率都显著降低.
结论:
- 加达西尔-4疫苗有效地减少了性活跃的年轻女性的HPV感染.
- 在这一群体中,HPV疫苗似乎没有影响性行为.
- 结果支持HPV疫苗作为预防宫癌的关键工具,尽管覆盖面有挑战.
更多相关视频
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
27.4K
11:14Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
9.2K
相关概念视频
01:30Cancer Vaccines
363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363
01:51Vaccinations
44.5K
Overview
44.5K